VirtualScopics, Inc. Schedules First Quarter 2014 Financial Results Press Release And Conference Call

PR Newswire

ROCHESTER, N.Y., May 1, 2014 /PRNewswire/ -- VirtualScopics, Inc. (VSCP), a leading provider of quantitative imaging solutions, today announced it will report its first quarter 2014 financial results before the market opens on Thursday, May 15, 2014.  Eric Converse, interim chief executive officer, and Jim Groff, acting chief financial officer, will host a conference call to discuss the company's financial results and provide a business update at 8:30 a.m. ET that morning.  Conference call and replay information is as follows:   

Domestic Call Dial In:  877-407-8035 
International Call Dial In:  201-689-8035
Conference Call ID:  13581706

An accompanying slide presentation to enhance managements' formal remarks, as well as a webcast of the call, can be accessed at

A replay and slide presentation will be available one hour after the conclusion of the conference call for 90 days, and can be accessed accordingly:

Replay Domestic Dial In:  877-660-6853
Replay International Dial In:  201-612-7415
Replay Conference Call ID:  13581706
Webcast and slide presentation:

About VirtualScopics, Inc.
VirtualScopics, Inc. (VSCP) is a leading provider of quantitative imaging solutions to accelerate drug and medical device development.  For risk-adverse, time-constrained Clinical Trial Study Teams, Medical Directors and Imaging Scientists who require quality imaging data delivered on-time, within budget and on a consistent basis, VirtualScopics' clinical trial imaging solutions are an inspired true exception to commonly accepted services provided by other clinical trial imaging providers.  Because of the scientific and operational flexibility and responsiveness they can offer, VirtualScopics' clinical trial imaging solutions deliver special performance advantages compared to other image service providers that offer common, every day clinical trial imaging services.  For more information about VirtualScopics, Inc. please visit

For more information, contact:
Donna N. Stein, APR, Fellow PRSA
Managing Partner, Donna Stein & Partners


View Comments (0)